A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/1997
12/03/1997	CN1166355A Medicine powder for prostatitis
12/02/1997	US5693805 Sulfonamidation of chlorosulfonylcamphor with piperazine derivative salt, oximation, reduction, selective amidation of endo amine isomer, salt formation; tocolytic agents
12/02/1997	US5693656 Methods for inhibiting endometriosis
12/02/1997	US5693639 Therapeutic heterocyclyl amionosulfonyl phenyl compounds
12/02/1997	US5693637 Bicycle derivatives, their preparation and use
12/02/1997	US5693633 Angiotensin II antagonists
12/02/1997	US5693628 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
12/02/1997	US5693479 Obtaining trophoblast sample from conceptus prior to uterine implantation of the conceptus, administering transforming growth factor to sample, evaluating production by the sample of trophoblast fibronectin
11/1997
11/30/1997	CA2206466A1 Carbamoyl substituted heterocycles
11/27/1997	WO1997044460A1 Modulators of tissue regeneration
11/27/1997	WO1997044457A1 Polycystic kidney disease gene
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997	WO1997038665A3 Inhibitors of farnesyl-protein transferase
11/27/1997	CA2254083A1 Polycystic kidney disease gene
11/26/1997	EP0808900A2 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
11/26/1997	EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
11/26/1997	EP0808318A1 Tricyclic substituted hexahydrobenz e]isoindole alpha-1 adrenergic antagonists
11/26/1997	EP0808166A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
11/26/1997	EP0808163A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
11/26/1997	EP0808104A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS
11/26/1997	EP0808103A1 Protein hydroxylation inhibitors for fibroproliferative disorders
11/26/1997	CN1165689A Medicine for treating prostate hyperplasia and method of prepn. of the same
11/26/1997	CN1165680A Medicine for treating chronic kidney disease and its prepn. method
11/26/1997	CN1165655A Method of treating conditions with estrogen agonists
11/26/1997	CN1165651A Use of (E)-1£4'-(2-alkylaminoethioxy) phenyl\|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
11/26/1997	CN1165649A Method of increasing testostrone
11/25/1997	US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997	US5691355 Syneristic mixture; therapy for breast cancer
11/25/1997	US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds
11/25/1997	US5691347 Angiotensin ii inhibitors and vasoconstriction
11/25/1997	US5691160 Elution and quantitative analysis of actin in clots with incubation
11/20/1997	WO1997043260A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997042956A1 Didhydropyrimidines and uses thereof
11/20/1997	CA2253876A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	CA2253862A1 Dihydropyrimidines and uses thereof
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997	EP0807628A1 Aromatic compound and pharmaceutical composition
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0806952A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding
11/19/1997	EP0806948A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin
11/19/1997	EP0806947A1 Formulations and methods for reducing skin irritation
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688818 Enzyme inhibitors
11/18/1997	US5688795 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
11/13/1997	WO1997042187A1 Oxindole derivatives
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997041881A1 Morphogen treatment for chronic renal failure
11/13/1997	WO1997041880A1 Therapies for chronic renal failure
11/12/1997	EP0805813A1 Tricyclic vasopressin antagonists
11/12/1997	EP0805812A1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists
11/12/1997	CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997	CN1036396C Process for preparing (E)-3-£2-n-butyl-1-{(4-carboxyl-phenyl)methyl}-1H-imidazol-5-yl}-2-(2-thienyl) methyl-2-acrylic methylsulfonate
11/12/1997	CN1036392C Method for preparation of ring-substituted 2-amino-tetralin and 3-aminochromanes
11/11/1997	US5686485 Physiologically active EI-1941 compounds
11/11/1997	US5686478 Endothelin antagonists
11/11/1997	US5686467 2-phenyl-3-aroylbenzothiophenes
11/11/1997	US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997	US5686454 Preventing labor, vasodilation, diuresis, hypotensive agents, anticoagulants, treating dysmenorrhea
11/11/1997	US5686444 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/11/1997	US5686425 Composition and method for revitalizing scar tissue
11/11/1997	US5686409 Administering serine protease inhibitor
11/11/1997	US5686289 Seeding hollow fibers with renal tubule cells, culturing in presence of retinoic acid and epidermal growth factor, cell differentiation
11/11/1997	US5686097 Hormone replacement therapy, glycerol monolaurate, lauryl lactate
11/06/1997	WO1997041121A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997	WO1997041120A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
11/06/1997	WO1997040850A1 Erythropoietin solution preparation
11/06/1997	WO1997040680A1 Antioxidant compound
11/05/1997	EP0804471A1 Gnrh antagonists
11/05/1997	EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804435A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/05/1997	EP0804420A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997	EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/04/1997	US5684198 Method of preparing therapeutic amides
11/04/1997	US5684145 Carrier system against GNRH
11/04/1997	US5684047 4-guanidinobutyramide for improving blood circulation
11/04/1997	US5684033 Antiarthritic agents, analgesics and migraine
11/04/1997	US5684028 Sulphorous derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions
11/04/1997	US5684015 Angiotensin antagonist as hypotensive agents and cardiovascular disorders
11/04/1997	CA2025413C S-triazolo¬3,4-i\|purine derivatives
10/1997
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040045A1 Heterocyclic compounds and their preparation and use
10/30/1997	WO1997040006A2 Phosphate mimics
10/30/1997	CA2252778A1 Phosphate mimics
10/30/1997	CA2252563A1 Heterocyclic compounds and their preparation and use
10/29/1997	EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors
10/29/1997	EP0803256A1 Drug for relieving side effects caused by immunosuppressants
10/29/1997	EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/28/1997	US5681817 Treatment of ovarian estrogen dependent conditions
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors

1 ... 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 ... 562